|Day's Range||40.79 - 41.48|
|52 Week Range||37.20 - 45.58|
|PE Ratio (TTM)||46.00|
|Dividend & Yield||1.95 (4.62%)|
|1y Target Est||N/A|
GlaxoSmithKline axed more than 30 drug-research projects to focus on four key disease areas, in a push by new Chief Executive Emma Walmsley to sharpen the company’s research-and-development operations....
GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals ...